Free Trial

NBW Capital LLC Sells 27,177 Shares of HealthEquity, Inc. (NASDAQ:HQY)

HealthEquity logo with Medical background

Key Points

  • NBW Capital LLC reduced its stake in HealthEquity, Inc. by 34.3%, holding 51,986 shares worth approximately $4.59 million at the end of the first quarter.
  • HealthEquity reported earnings of $0.97 per share, exceeding analyst expectations of $0.81, with a revenue of $330.8 million for the quarter.
  • Several analysts have increased their price targets for HealthEquity, with Barrington Research setting a new target of $125 and Raymond James updating theirs to $120.
  • Looking to Export and Analyze HealthEquity Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

NBW Capital LLC trimmed its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 34.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,986 shares of the company's stock after selling 27,177 shares during the period. NBW Capital LLC owned approximately 0.06% of HealthEquity worth $4,594,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Citigroup Inc. raised its holdings in shares of HealthEquity by 5.3% in the 1st quarter. Citigroup Inc. now owns 194,286 shares of the company's stock worth $17,169,000 after acquiring an additional 9,798 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of HealthEquity by 9.7% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,166 shares of the company's stock worth $191,000 after acquiring an additional 192 shares during the last quarter. Ontario Teachers Pension Plan Board acquired a new stake in shares of HealthEquity in the 1st quarter worth about $745,000. Charles Schwab Investment Management Inc. raised its holdings in shares of HealthEquity by 1.3% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,100,970 shares of the company's stock worth $97,293,000 after acquiring an additional 14,159 shares during the last quarter. Finally, New Age Alpha Advisors LLC raised its holdings in shares of HealthEquity by 755.8% in the 1st quarter. New Age Alpha Advisors LLC now owns 22,175 shares of the company's stock worth $1,960,000 after acquiring an additional 19,584 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Performance

Shares of HQY stock traded up $1.21 during trading hours on Friday, hitting $93.05. 616,384 shares of the company were exchanged, compared to its average volume of 905,203. The firm has a fifty day simple moving average of $100.26 and a 200 day simple moving average of $97.83. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. HealthEquity, Inc. has a 52-week low of $69.52 and a 52-week high of $116.65. The stock has a market capitalization of $8.05 billion, a price-to-earnings ratio of 67.92, a P/E/G ratio of 1.44 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The company had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. During the same quarter last year, the business posted $0.80 EPS. Research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In other HealthEquity news, Director Jon Kessler sold 134,183 shares of the firm's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.08, for a total value of $15,039,230.64. Following the completion of the transaction, the director directly owned 253,510 shares of the company's stock, valued at $28,413,400.80. This trade represents a 34.61% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Henry Fiore sold 1,794 shares of the firm's stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. The trade was a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 291,744 shares of company stock valued at $32,705,007. Company insiders own 1.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Royal Bank Of Canada upped their target price on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a report on Wednesday, June 4th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. Barrington Research increased their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research note on Thursday, June 5th. Raymond James Financial reiterated a "strong-buy" rating and issued a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Finally, KeyCorp decreased their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $118.55.

View Our Latest Analysis on HQY

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

See Also

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines